BASTOS, M., GUTIERREZ, A., Reguera, J. L., Iacoboni García-Calvo, G., Lopez Corral, L., Terol, M. J., . . . Abrisqueta, P. (2022). Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups.
Citación estilo ChicagoBASTOS, MARIANA, ANTONIO GUTIERREZ, Juan Luís Reguera, Gloria Iacoboni García-Calvo, Lucia Lopez Corral, M. Jose Terol, Pere Barba Suñol, y Pau Abrisqueta. Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups. 2022.
Cita MLABASTOS, MARIANA, et al. Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups. 2022.